Wall Street’s Stealth Buy-In vs. Main Street’s Sell-Off: Who’s Winning?
A dramatic shift is unfolding as retail investors, after 36 weeks of relentless buying, have turned net sellers, offloading $700 million in U.S. equities last week—their second sale in three weeks—with a four-week average sale of $200 million. Meanwhile, institutional investors are quietly stepping up, purchasing $1.1 billion last week, marking six consecutive weeks of inflows, the longest streak since the 2022 bear market, with a four-week average buy of $1.7 billion. The S&P 500 holds at 6,590, Nasdaq sits at 22,150, and Bitcoin steadies at $125,200, while the VIX dips to 13.80 and oil hovers at $74.20/barrel. Posts found on X highlight “Wall Street’s edge” and “retail fatigue,” sparking debate. This deep dive explores the investor divide, market dynamics, key sectors, outlook, tradi
$Opendoor Technologies Inc(OPEN)$ 🏠 Opendoor Rockets! Would You Take Profit at $10? 🚀 Opendoor Technologies ($Opendoor Technologies Inc(OPEN)$ ) has become one of the most talked-about momentum trades of the summer. The stock surged 50% in a single week after the company announced a leadership shake-up — appointing a new CEO while bringing in Keith Rabois, a well-known tech investor and early PayPal Mafia member, as chairman. For many retail traders, that was all the spark needed to push the stock above $8, with chatter now focused on whether $10 is next. But behind the fireworks lies a deeper debate: is Opendoor finally turning a corner with its AI-driven real estate platform, or a
🚀 Figure vs Gemini: Who Will Rule the Fintech Spotlight? The fintech market just got a double dose of excitement. Figure Technologies $Figure Technology Solutions(FIGR)$ surged +24% on debut, riding investor enthusiasm around its blockchain-based lending model and strong demand for its IPO. Now, all eyes turn to Gemini, set to start trading tonight with a Nasdaq partnership that promises custody, staking, and collateral management infrastructure. This sets up the perfect rivalry: one company already off to a flying start, the other backed by heavyweight partnerships before its first trade. The question retail investors are asking: will Gemini outperform Figure’s breakout, or is Figure’s early momentum too strong to beat? --- 📊 Figure’s
Lulu Drops for 3 Quarters: Back to 2020 Lows - Buy the Dip?
I’ve always been a fan of Lululemon. Their products—athletic apparel, footwear, and accessories—combine style, quality, and functionality in a way few brands manage. From sleek leggings to cozy hoodies, they make workout gear that people actually want to wear outside the gym. It’s no wonder Lululemon has cultivated such a loyal following. But when it comes to their stock, things have been rough lately. Lululemon (LULU) has now dropped for consecutive quarters, recently hitting levels not seen since 2020. The company topped second-quarter earnings estimates but slightly missed revenue expectations. More concerningly, Lululemon said the effect of tariffs and the removal of the de minimis exception are hitting its sales. Tariffs, competition, and headwinds from peers like Alo have weighed hea
$Tesla Motors(TSLA)$ 🦾🚘📈🅱️U̥ L̥ L̥ I̥ S̥ H̥📈🤖🔋 I’m watching the power of the $351 break. Market makers are clearly offsides and the chase is on. TSLA has ripped to $394.80 (+7.05%) with intraday call walls stacked at $400. Gamma exposure clusters sit near $391, with heavy ITM flow confirming strength. Support rests at $368.27 and $356.95, while upside resistance lies at $400–420. With OI stacked across 390c–405c and IV at 61.92%, the setup favors continuation. Was $351 ever retested? That level now feels like a launchpad. 📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the
My first Singapore stock was Singtel. my favourite REIT is CICT, it owns many malls and offices in Singapore and is a largest REIT on SGX with 90% exposure to Singapore. I invest in SGX because it is my home market and I get to interact and speak to the people working in these companies easier
Healthy Profits or Price Headache? UNH’s Road to $400
UnitedHealth Group is a stock in need of a second opinion. Trading at $353, down more than 40 per cent from its 52-week high, it sits at a valuation multiple of just 15 times earnings — modest for a company that still pulls in over $420 billion in annual revenue. The market is clearly pricing in lasting damage. I think the case is more nuanced. If Optum can recover margins, if Medicare Advantage scrutiny is contained, and if capital returns are deployed with conviction, then the climb back to $400 is achievable. Networks align: Optum’s reach could redraw healthcare’s balance sheet Optum’s margin pulse Optum has become the engine that keeps $UnitedHealth(UNH)$ competitive. It now accounts for nearly half of operating earnings, yet recent quarters ha
so exciting to see the name catchup as every other Mag 7 was green YTD, now $TSLA is up about 4% this year after the move seems like the robotaxi nevada headlines are helping it, along with Elon saying "the govt is unfixable" and people feeling he's going to be much more into tesla over politics EV tax credit expiring end of month seems to be creating enough demand for this to be a 500K+ delivery quarter for Tesla hard to fade fsd, energy, and robotics over the next decade but 2026 earnings, as per elon, won't inflect until around Q3 next year street seems to be pulling forward that growth as the entire market begins to make a move higher also lower rates = bullish for buying cars
I’d agree that timing and conviction often matter more than simply holding for a long horizon. Nvidia, Tesla, and Palantir all had clear inflection points where their narrative shifted from “niche” to “mainstream,” and the outsized returns went to investors who recognised those moments early. As for emerging names with moat-based innovation potential, I’d keep an eye on companies in AI infrastructure (e.g., semiconductor design beyond GPUs), synthetic biology, and energy storage. The common thread is that these sectors have steep barriers to entry, compounding advantages from scale or data, and long runways for growth. Holding for 15 years only works if the company keeps compounding. But recognising the “iPhone moment”—where technology meets mass adoption—is what really separates exponenti
Is Tesla's China Surge the Next Quantum Leap in Share Price?
🌟🌟🌟Tesla $Tesla Motors(TSLA)$ just lit up the Chinese EV market with a surprise hit - the Model Y L, a long wheelbase, 6 seater SUV tailored for multi generational families. Within days of launch, the Model Y L sold out through November, racking up over 120,000 orders. Investors responded with a 5% surge in Tesla share price. However the real question isn't just about 1 vehicle. It is about a company rewriting its destiny. Elon Musk isn't just selling cars anymore. He is pitching a future where AI, humanoid robots and autonomous fleets drive Tesla's next Trillion Dollar quantum leap. With a proposed USD 1 Trillion performance package tied to milestones like deploying 1 million Optimus robots and robotaxis,
Technical Breakout at the Gates: CapitaLand Ascott Trust Eyes S$0.92 Resistance for Next Bull Run
Technical Analysis (as of 13 Sep 2025) The chart shows a steady recovery in $CapLand Ascott T(HMN.SI)$ price since April 2025, forming a clear horizontal resistance band slightly above the S$0.90 level. Multiple attempts to break above this resistance (marked by circles) have occurred in 2024 and 2025, making S$0.91–0.92 a key breakout zone. The price is currently testing this resistance with higher volume, and a clear breakout could indicate further bullish momentum. The 20, 40-day EMA, and 50-day SMAs are stacked bullishly above the 200-day MA, confirming a short-term uptrend. Price has consistently found support near S$0.86 (major historical support zone). The current structure suggests increasing accumulation and reduced volatility. Watch fo
🚨🚨Market Analysis September 13, 2025 Showed a mixed picture with an overall focus on the anticipation of a potential interest rate cut by the U.S. Federal Reserve. This expectation is driven by recent economic data, including a rise in jobless claims and cooling inflation. Here is a summary of the market analysis: U.S. Markets: * Mixed Performance: On Friday, September 12, the S&P 500 saw a slight dip, while the Nasdaq Composite reached a new record high, and the Dow Jones Industrial Average fell. However, all three indices finished the week with gains. * Key Drivers: Investor sentiment is heavily influenced by the belief that the Fed will cut interest rates, possibly by 25 basis points, at its upcoming meeting. This has been a significant factor in lifting major U.S.
ATCH: The Fintech Underdog Poised for a Monumental Rally in 2025
In the volatile world of penny stocks, few names have captured the imagination of savvy investors like AtlasClear Holdings, Inc. (NYSE American: ATCH). Trading at a mere $0.39 as of September 13, 2025, this micro-cap fintech powerhouse has endured a brutal year, down nearly 96% year-to-date amid broader market headwinds. But beneath the surface lies a story of transformation, resilience, and untapped potential. With explosive subsidiary growth, strategic expansions into high-growth sectors like crypto and stock lending, and a slate of upcoming catalysts, ATCH isn’t just surviving—it’s gearing up for a breakout. For contrarian investors eyeing the next big multiplier, this could be your ticket to outsized gains. A Turnaround Fueled by Subsidiary Firepower At the heart of ATCH’s resurgence i
Tesla Options Volume Jump as EV Maker Sees Millions of Dollars in Bearish Trades $Tesla Motors(TSLA)$ 's options volume jumped as the electric vehicle giant saw millions of dollars in bearish block trades after shares jumped to their highest intraday level since January. Shares advanced as much as 7.4% to $395.99 before paring the gains to $394.67. The stock headed for a fourth straight day of gains after media reports that the company got a permit from Nevada's Department of Vehicles to begin testing its autonomous vehicle technology on public roads. That could take Tesla a step closer to its goal of launching an autonomous ride-hailing service in the U.S., a target that CEO Elon Musk said in July
Opendoor, Warner Bros. are Most Shorted Stocks After Big Rally $Opendoor Technologies Inc(OPEN)$ shares pulled back Friday after their 80% jump Thursday unleashed a barrage of short positions, making the stock the most shorted. Trading on Opendoor shares almost tripled Thursday, taking its market capital above $7 billion for the first time in more than three years, after the company named $Shopify(SHOP)$ Chief Operating Officer Kasra Nejatian as its new CEO, and announced that its co-founders are returning to the board. As the stock was climbing, 133.85 million borrowed Opendoor shares were sold short Thursday, up from 3
Munger’s Wisdom: Can You Stomach a 50% Market Crash and Still Win?
Charlie Munger’s stark warning rings true: if a 50% market drop every few decades shakes your resolve, you’re not cut out for the shareholder life—and mediocre returns await. History backs him up, with the S&P 500 plunging 49% in 2008 and 34% in 2020, yet rebounding to 6,600 today. Munger’s philosophy demands equanimity amid chaos, turning dips into opportunities. Are you ready for the next big fall? How do past crashes shape today’s strategy? Let’s unpack the lessons, analyze current risks, and build a plan to thrive when markets tumble. Market Crashes: A Century of Volatility Munger’s insight draws from real cycles: Dot-Com Bust (2000): S&P 500 fell 49% from 1,527 to 777, recovering in 5 years to 1,400. Financial Crisis (2008): A 57% drop from 1,565 to 676, with a 6-year climb ba
Shocking Drop: Pfizer and Moderna Tumble as Vaccine Death Claims Surface!
$Pfizer(PFE)$$Moderna, Inc.(MRNA)$ The pharmaceutical world is reeling as Pfizer and Moderna stocks plummeted following reports that U.S. officials plan to link COVID-19 vaccines to the deaths of 25 children. Pfizer slid 3.7% to $27.45, while Moderna crashed 8% to $18.20, erasing billions in market value amid a Washington Post story citing unverified VAERS data. This controversy, tied to a Trump administration presentation to the CDC panel, has sparked outrage and uncertainty. Will this derail vaccine trust? How will it reshape the biotech sector? Dive into the fallout, assess the risks, and uncover trading moves in this unfolding crisis. The Controversy Unraveled: What’s Behind the Drop? The news hit lik
$Advanced Micro Devices(AMD)$$NVIDIA(NVDA)$ 🚀🔥⚡ $AMD IHS Breakout Targeting $165 ⚡🔥🚀 I’m convinced $AMD is setting up for an IHS retest toward $165 this month. Price is stabilizing near $158 support with a measured extension to $165.36, while downside risk sits at $150.38. The technicals align with a rhetoric shift that’s even more bullish than the chart itself. Moving from “no solution fits all” to “we will surpass NVIDIA” is a declaration of intent that matches this structure. Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀
$TSLA 20250919 375.0 CALL$ once tsla breaks out its like a rocket ship shooting past resistance levels like a hot knife ttrough butter. I will just roll this call up to a higher strike next week. The likelihood of assignment Is very low